Latest news

Hide mandatory notifications of trade

GLOBVAC`s new policy brief on HIV research includes Bionor Pharma`s vaccine development

GLOBVAC is the Norwegian Research Councils Program for Global Health and
Vaccination Research. Bionor Pharma`s research supported by GLOBVAC,
and further plans to develop effective HIV-vaccines, are described in one
out of four articles in GLOBVAC's document “New policy brief on HIV research”,
published February 2013. See the policy document here, and read the article
about Bionor Pharma on page 3.

For more information about GLOBVAC, see this link